Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index.

ABSTRACT:

Introduction and hypothesis

A prospective clinical, preliminary study was performed in patients with interstitial cystitis/bladder pain syndrome (IC/BPS) who were nonresponders to conventional treatment and received intravesical ozone as a therapeutic alternative.

Methods

Sixteen patients received six applications of intravesical ozone at a concentration of 41 μg/mL. We evaluated therapeutic efficacy by the percentage reduction of Interstitial Cystitis Symptom and Problem Index scores (ICSI/ICPI-the O'Leary-Sant symptom index), recurrence rate, nonresponse, and side effects in scores collected on admission (pre-treatment), at the end of the therapeutic protocol (post-treatment), and 180 days (follow-up) after the last ozone application.

Results

The mean age of women w

SUBMITTER: Pires MV 

PROVIDER: S-EPMC9569001 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature